2505, Avenue Dalton
QC G1P 3S5
Canada - Map
TSO3 Inc. is engaged in the research, development, commercialization, and licensing of sterilization processes, related consumable supplies, and accessories for heat-sensitive medical devices in Canada and internationally. Its products include Sterizone 125L+ sterilizer for the reprocessing of general instrumentation, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes; and 125L Ozone sterilizer for heat-and moisture-sensitive medical devices, such as general stainless steel instruments and rigid endoscopes. The company also offers 125-280 Solution, a 50% stabilized hydrogen peroxide; and develops STERIZONE 80L sterilizer that targets the need for a smaller device or sub-sterile in North America. In addition, it provides product development services to medical device manufacturers that include hydrogen peroxide and ozone sterilization validation, compatibility testing, medical devices cleaning method development, and medical packaging compatibility verification. The company was founded in 1998 and is headquartered in Quebec, Canada.
|Mr. Richard M. Rumble ,
Chief Exec. Officer, Pres, Director and Chairman of Advisory Committee
|Dr. Beno Deschamps MBA, Ph.D.,
Chief Financial Officer, VP of Fin. and Sec.
|Mrs. Paule De Blois M.B.A., C.H.R.P,
Gen. Mang. of Admin.
|Ms. Caroline Cote ,
Director of Investor and Bus. Relations
|Mr. Robert F. Mosher ,
Vice-Pres of Global Marketing
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in CAD.|